Keeping "bad" cholesterol in check and increasing "good" cholesterol is not only good for your heart, but also your brain, new research suggests. A study from the University of California, Davis, found that low levels of "bad" (LDL) ...
Tags: cholesterol level, Alzheimer's disease, healthy cholesterol levels
Bioanalytical Systems,Inc.(NASDAQ:BASI)today announced financial results for the fourth quarter and fiscal 2013,highlighted by net income of$252,000,or$0.03 per diluted share,for the fourth quarter and$773,000,or$0.09 per diluted share,for ...
Tags: Bioanalytical Systems, financial results for the fourth quarter
The flu vaccine is less effective for men than women, and researchers at Stanford University believe they've figured out why. The male hormone testosterone causes genes in the immune system to produce fewer antibodies, or defense ...
Tags: flu vaccine, male hormone, testosterone, the immune system, men health
Vector Capital, private equity firm focused on value-oriented investments in technology companies, has sold Certara, a provider of drug development software and services, to Arsenal Capital Partners, a US-based based private equity firm. ...
Tags: Vector Capital, Arsenal Capital
Belgium-based FLUIDDA has developed proprietary functional respiratory imaging (FRI) technology that provides a unique entry point into personalized medicine for respiratory diseases. FRI reduces significantly the number of patients ...
Boehringer Ingelheim has entered into a research collaboration agreement with and Circuit Therapeutics to discover new ways of treating psychiatric disorders. As per the deal, the companies will combine their research and development ...
Tags: Boehringer, Psychiatric Disorders
Merck Serono has signed a license agreement with the Spanish National Cancer Research Centre (CNIO) in Madrid in the area of cancer drug development and will build upon CNIO research discoveries to support the development and ...
Tags: Cancer Patients, Merck Serono
The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have announced the launch of a joint initiative to share information on inspections of bioequivalence studies submitted in support of generic drug approvals. ...
Tags: Generic Drug, Medicine
Siemens Healthcare Diagnostics and Pfizer have entered into a master collaboration agreement to design, develop and commercialize diagnostic tests for therapeutic products across Pfizer’s pipeline. Pursuant to the terms of the ...
Tags: Siemens, Pfizer, Companion Diagnostics
Stelis Biopharma and Pieris, a next generation therapeutic protein R&D firm, have started a long-term collaboration for clinical development and commercialization of multiple novel Anticalin-based protein therapeutics worldwide, primarily ...
NanoViricides has received results of detailed lab analysis studies from the initial non-GLP toxicology studies of intravenously administered FluCide. No overt adverse safety and toxicology effects were observed in this study of the ...
Taiwan-based JHL Biotech and Switzerland-based Selexis have formed a biologic drug development alliance to serve the biopharmaceutical industry. JHL Biotech and Selexis have signed a non-exclusive strategic agreement to provide seamless ...
Tags: Health, Medicine, taiwan, Biologic Drug
CDRD Ventures, the commercialization vehicle of The Centre for Drug Research and Development (CDRD), has announced the launch of a new spin-off company, Sitka Biopharma is a biotechnology company developing a new bladder cancer treatment. ...
Novogen, a biotechnology company, has announced the filing of a family of provisional patents in the US covering anti-tropomyosin (ATM) drug technology. ATM drugs represent an entirely novel approach to anti-cancer therapy, blocking the ...
US-based research and development biotechnology firm Boston Strategics has entered into a new drug development partnership with Fujifilm Pharmaceuticals USA (FPHU), a global pharmaceutical development center of Japan's Fujifilm Corporation. ...
Tags: Oncology Drugs, Fujifilm Pharma